STAAR Surgical to report FY2024 earnings Feb 19; global ICL sales double-digit YoY except China

STAAR SURGICAL CO

Earnings release for Q4 and FY2024 set for Feb 19 after market close; conference call at 4:30pm ET.
CEO Frinzi states double-digit YoY ICL sales growth globally in FY2024, with the exception of China.
Persistent economic conditions and lower consumer confidence in China cited as headwinds for that market.
Chinese New Year period seen as key proxy for consumer demand; recent stimulus may inform FY2025 outlook.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.